Bank of N.T Butterfield Azioni (NYSE: NTB)

Bank of N.T Butterfield (NYSE:NTB) Azioni

Bank of N.T Butterfield

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.

WIIM

TNXP

Tonix Pharmaceuticals shares are trading higher after the company announced the presentation of new findings on TNX-801 at the Vaccine Congress 2025 in Vienna.

Keefe, Bruyette &amp; Woods analyst Bose George maintains Stewart Information Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STC#NYSE">STC</a>) with a Market Perform and lowers the price target from $75 to $72.

News

Price Target

Analyst Ratings

Keefe, Bruyette & Woods Maintains Market Perform on Stewart Information Servs, Lowers Price Target to $72

<a href="https://www.youtube.com/watch?v=K0UwLfevw24">https://www.youtube.com/watch?v=K0UwLfevw24</a>

Macro Economic Events

Politics

Economics

General

Fed's Musalem Says Not Hearing From Firms That There Are Supply Chain Disruptions

XCF Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAFX#NASDAQ">SAFX</a>) stock is trading higher on Thursday, with a session volume of 95.7 million compared to the average volume of 6.21 million <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">as per data from Benzinga Pro</a>.
A key player in decarbonizing the aviation industry through Synthetic Aviation Fuel (SAF), the company shared its strategic plan to invest close to $1 billion in developing a network of SAF production facilities, expanding its U.S. footprint, and advancing its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/ac46339803/xcf-global-outlines-plan-to-build-multiple-saf-production-facilities-and-invest-nearly-1-billion-" rel="noreferrer noopener">international growth strategy</a>.
From inception, approximately $350 million has been invested to bring New Rise Reno online which has created approximately 60 full-time management, engineering, and related jobs in the Reno-Tahoe area.
Also Read: <a href="https://www.benzinga.com/node/46338975">Top 3 Energy Stocks Which Could Rescue Your Portfolio For July</a>
More than 2 billion people globally live in countries with SAF blending mandates or strong incentives like tax credits &#8211; by 2030, this number is expected to grow to more than 4 billion people.
Expanding global demand underpins XCF&#8217;s decision to scale production at home and internationally, ensuring the company is positioned to serve markets where policy, aviation demand, and decarbonization goals align.
&#8220;We&#8217;re not simply dreaming about decarbonizing the aviation industry &#8211; we&#8217;re building it right now,&#8221; said Mihir Dange, Chief Executive Officer and Board Chair of XCF. &#8220;With over $350 million already invested through New Rise Reno, we&#8217;ve proven that we can bring large-scale, commercial SAF production online. Our strategy is to invest nearly $1 billion over the next three years to develop multiple production facilities that will deliver real volumes, real revenue, and real impact for our shareholders.&#8221;
<h2 class="wp-block-heading">U.S. Growth Pipeline</h2>
XCF&#8217;s U.S. expansion plan includes three additional production sites that have already been acquired and are ready for development. Each facility is expected to have a nameplate production capacity of 40 million gallons. 
Together with New Rise Reno, these sites are expected to deliver a total production capacity of approximately 160 million gallons per year by the end of 2028.
The first new facility, New Rise Reno 2, will be adjacent to the existing New Rise Reno facility, enabling economies of scale and leveraging shared utilities and logistics infrastructure; this facility is expected to be completed in 2027. 
The second facility will be in Ft. Myers, Florida, chosen due to growing SAF demand in the Southeast U.S. and access to port infrastructure; this facility is expected to be completed by 2028. 
Finally, the third facility will be in Wilson, North Carolina, strategically located to serve East Coast markets and support local economic development; this facility is also expected to be completed by 2028.
<h2 class="wp-block-heading">International Expansion Strategy</h2>
In addition to its U.S. pipeline, XCF is pursuing an international growth strategy to expand its platform into high-potential global markets.
The company recently signed a Memorandum of Understanding (MOU) to launch New Rise Australia, a new SAF and renewable diesel production platform in partnership with Continual Renewable Ventures.
Price Action: SAFX stock is up 70.7% at $2.56 at the last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46344382/united-airlines-american-airlines-stocks-rise-on-deltas-bullish-forecast" target="_blank" rel="noreferrer noopener">United Airlines, American Airlines Stocks Rise On Delta&#8217;s Bullish Forecast</a></li>
</ul>
Image via Shutterstock

Movers

SAFX

XCF Global Bets Big On Sustainable Aviation Fuel With $1 Billion Investment

Wells Fargo analyst Elyse Greenspan maintains MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) with a Overweight and raises the price target from $94 to $97.

Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $97

Keefe, Bruyette &amp; Woods analyst Timothy Switzer maintains SoFi Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) with a Underperform and raises the price target from $9 to $13.

SOFI

Keefe, Bruyette & Woods Maintains Underperform on SoFi Technologies, Raises Price Target to $13

Wells Fargo analyst Elyse Greenspan maintains Lincoln National (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNC#NYSE">LNC</a>) with a Equal-Weight and raises the price target from $33 to $35.

Wells Fargo Maintains Equal-Weight on Lincoln National, Raises Price Target to $35

Wells Fargo analyst Elyse Greenspan maintains Globe Life (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GL#NYSE">GL</a>) with a Overweight and raises the price target from $139 to $144.

Wells Fargo Maintains Overweight on Globe Life, Raises Price Target to $144

Keefe, Bruyette &amp; Woods analyst Bose George downgrades Redwood Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RWT#NYSE">RWT</a>) from Outperform to Market Perform and lowers the price target from $7 to $6.5.

Downgrades

Keefe, Bruyette & Woods Downgrades Redwood Trust to Market Perform, Lowers Price Target to $6.5

Wells Fargo analyst Elyse Greenspan maintains Equitable Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQH#NYSE">EQH</a>) with a Overweight and raises the price target from $61 to $66.

Wells Fargo Maintains Overweight on Equitable Holdings, Raises Price Target to $66

Wells Fargo analyst Elyse Greenspan maintains Brighthouse Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHF#NASDAQ">BHF</a>) with a Equal-Weight and raises the price target from $53 to $54.

Brighthouse Financial, Inc. - Common Stock

Wells Fargo Maintains Equal-Weight on Brighthouse Finl, Raises Price Target to $54

&nbsp;&nbsp;&nbsp;&nbsp;Most people hope to walk into retirement with a nice little nest egg. But what if you&#8217;re staring down a $1.6 million check and wondering, Should I take it — or let the pension ride? That was the exact dilemma one New York City couple brought to Dave Ramsey.
Melissa <a href="https://www.youtube.com/watch?v=-FG5zx8pqeo">called into "The Ramsey Show"</a> to talk about her husband's upcoming retirement and the "final papers" in front of him. At 55 years old, he had a choice: take a $1.6 million lump sum now, or stick with traditional pension payments that would end upon death — or shortly after.
Ramsey didn't hesitate. "There&#8217;s very few times, folks, that you won&#8217;t take the lump sum on a pension," he said. "And that's the reason — 'cause you lose it all when you die. That's it. You get zero."
Don't Miss:
<ul class="wp-block-list">
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
The couple had been offered various survivorship options, including a 100% benefit to Melissa. But Ramsey wasn't impressed. "It only survives one generation past you, though. After that, it&#8217;s gone," he said.
He walked them through the math. If they rolled the lump sum into a traditional IRA and invested <a href="https://www.benzinga.com/personal-finance/25/02/44016490/21-year-old-pro-investor-challenges-dave-ramsey-show-hosts-on-index-funds-vs-mutual-funds-80-of-mutual-funds-dont-beat-the-market">it in a solid mix of mutual funds</a> — not touching the money — Ramsey said, "It'll double about every seven years."
Then came the eye-opener:
"You know, it's going to be $3.2 [million] after 7 years. At 69, it would be about $6 [million], and at 76 it&#8217;ll be… 14."
&nbsp;Melissa's reaction: "Holy mackerel."
&nbsp;Ramsey: "And <a href="https://www.benzinga.com/personal-finance/24/11/41991146/suze-orman-says-this-investment-can-make-your-kids-rich-by-retirement-you-have-a-golden-opportunity-to-launch-them-to-their-first-million">that all goes to your kid</a>. And their kid's kiddos. And so on."
Trending: It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
Compare that to the pension plan, he said, and it's no contest.
"100% of the time, [that money] does not go to them if you leave it in this stinkin' pension."
Ramsey also acknowledged Melissa's concern about market volatility. She mentioned the 2008 crash and the chaos of COVID. Ramsey reminded her of history.
"The Dow went down to 6,500 in 2008. ‘It's at 35,000 this week,' Ramsey said. Before you question the number, that was in 2021. For reference, the Dow's now around 44,829 in 2025, so his point held up."
He told her to zoom out and look at how the market rebounds after events like 9/11, Black Monday, and even Sputnik.
"You've got to get those numbers kind of down in your heart, or you&#8217;re going to freak out with this idea."
He capped it off with this advice:
"You roll it in a direct transfer traditional IRA… invest it in a good mix of mutual funds… and 100% of that money will pass to your heirs. It will not be left behind with a pension plan."
Ramsey didn't just frame it as a financial decision — he made it emotional, generational, and legacy-driven. And in his words, "It's easy math."
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence. </a></li>
</ul>
Image: Shutterstock

Personal Finance

55-Year-Old New York City Man Asks If He Should Take $1.6 Million Pension Lump Sum or Monthly Payments – Here's What Dave Ramsey Says To Do

Keefe, Bruyette &amp; Woods analyst Bose George maintains Rocket Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) with a Market Perform and raises the price target from $13 to $14.

Keefe, Bruyette & Woods Maintains Market Perform on Rocket Companies, Raises Price Target to $14

Chubb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) has outperformed the market over the past 5 years by 2.02% on an annualized basis producing an average annual return of 16.39%. Currently, Chubb has a market capitalization of $111.73 billion. 
Buying $100 In CB: If an investor had bought $100 of CB stock 5 years ago, it would be worth $217.64 today based on a price of $278.81 for CB at the time of writing.
<h3>Chubb's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752158805_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Chubb 5 Years Ago Would Be Worth Today

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 100 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.24% to 44,564.14 while the NASDAQ declined 0.44% to 20,520.54. The S&amp;P 500 also fell, dropping, 0.09% to 6,257.81.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46318208/top-2-tech-stocks-that-may-plunge-this-month">Top 2 Tech Stocks That May Plunge This Month</a>
Leading and Lagging Sectors Health care shares jumped by 0.9% on Thursday.
In trading on Thursday, communication services stocks dipped by 1.2%.
Top Headline
U.S. initial jobless claims declined by 5,000 from the previous week to 227,000 in the first week of July, compared to market estimates of 235,000.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Above Food Ingredients Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVE#NASDAQ">ABVE</a>) shares shot up 330% to $1.53 on continued strength following its merger agreement with Palm Global on Monday.</li>
<li>Shares of DallasNews Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DALN#NASDAQ">DALN</a>) got a boost, surging 218% to $13.55 after the company announced Hearst will acquire it for $14 per share.</li>
<li>BIT Mining Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCM#NASDAQ">BTCM</a>) shares were also up, gaining 117% to $5.34 after the company announced it plans an investment up to $300 million to expand into the Solana ecosystem.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Mereo BioPharma Group plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MREO#NASDAQ">MREO</a>) shares dropped 35% to $1.9150. Ultragenyx Pharmaceutical and Mereo BioPharma on Wednesday announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward a final analysis around the end of the year, consistent with the original plan.</li>
<li>Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RARE#NASDAQ">RARE</a>) were down 27% to $30.11. Ultragenyx Pharmaceutical and Mereo BioPharma on Wednesday announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward a final analysis around the end of the year, consistent with the original plan.</li>
<li>CURRENC Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) was down, falling 27% to $1.48 as the company announced the pricing of $60 million underwritten public offering at a price of $5/share.</li>
</ul>
Commodities In commodity news, oil traded down 1.8% to $67.14 while gold traded up 0.1% at $3,322.90.
Silver traded up 0.8% to $36.930 on Thursday, while copper rose 1.8% to $5.5885.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 rose 0.5%, while Spain's IBEX 35 Index fell 0.6%. London's FTSE 100 gained 1.1%, Germany's DAX 40 slipped 0.3% and France's CAC 40 gained 0.3% during the session.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei falling 0.44%, Hong Kong's Hang Seng gaining 0.57%, China's Shanghai Composite gaining 0.48% and India's BSE Sensex falling 0.41%.
Economics
U.S. initial jobless claims declined by 5,000 from the previous week to 227,000 in the first week of July, compared to market estimates of 235,000.
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46341009/how-to-earn-500-a-month-from-jpmorgan-stock-ahead-of-q2-earnings">How To Earn $500 A Month From JPMorgan Stock Ahead Of Q2 Earnings</a></li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

Intraday Update

Markets

ABVE

BTCM

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

DALN

MREO

RARE

US Stocks Mixed; Initial Jobless Claims Fall

Wells Fargo analyst Elyse Greenspan maintains Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Equal-Weight and raises the price target from $103 to $105.

Wells Fargo Maintains Equal-Weight on Aflac, Raises Price Target to $105

Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintains Ready Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RC#NYSE">RC</a>) with a Underperform and raises the price target from $3.75 to $4.25.

Keefe, Bruyette & Woods Maintains Underperform on Ready Capital, Raises Price Target to $4.25

Wells Fargo analyst Elyse Greenspan maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Overweight and lowers the price target from $387 to $369.

Wells Fargo Maintains Overweight on Willis Towers Watson, Lowers Price Target to $369

PTHS

Pelthos Therapeutics shares are trading higher after the company announced the launch of ZELSUVMI topical gel for the treatment of molluscum contagiosum in adults and pediatric patients one year of age and older.

Keefe, Bruyette &amp; Woods analyst George Bose maintains PennyMac Financial Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFSI#NYSE">PFSI</a>) with a Outperform and raises the price target from $114 to $121.

PFSI

Keefe, Bruyette & Woods Maintains Outperform on PennyMac Financial Servs, Raises Price Target to $121

Press Releases

Butterfield Reports Second Quarter 2024 Results

Butterfield Announces Senior Management Appointments

Butterfield to Announce Third Quarter 2024 Financial Results on October 22, 2024 and Host Earnings Conference Call on October 23, 2024

Butterfield Reports Third Quarter 2024 Results

Butterfield Announces New Share Repurchase Program

Butterfield to Announce Fourth Quarter and Full Year 2024 Financial Results on February 10, 2025 and Host Earnings Conference Call on February 11, 2025

Comments

Bank of N.T Butterfield

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO